Bill and Melinda Gates Foundation donations made to Infectious Disease Research Institute

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United States
Wikipedia pagehttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Best overview URLhttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Facebook username gatesfoundation
LinkedIn username bill-&-melinda-gates-foundation
Websitehttps://www.gatesfoundation.org/
Donations URLhttps://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database
Twitter usernamegatesfoundation
Page on philosophy informing donationshttps://www.gatesfoundation.org/What-We-Do
Grant application process pagehttps://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ
Regularity with which donor updates donations datacontinuous updates
Regularity with which Donations List Website updates donations data (after donor update)irregular
Lag with which donor updates donations datamonths
Lag with which Donations List Website updates donations data (after donor update)years
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing

Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett

Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief

Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database

Full donor page for donor Bill and Melinda Gates Foundation

Basic donee information

ItemValue
Country
Websitehttp://www.idri.org
Twitter usernameIDRItweets
Wikipedia pagehttps://en.wikipedia.org/wiki/Infectious_Disease_Research_Institute

Full donee page for donee Infectious Disease Research Institute

Donor–donee relationship

Item Value

Donor–donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 19 942,789 5,141,714 -2,590,788 500 500,000 680,000 773,722 942,789 3,386,540 3,837,627 7,031,776 29,947,850 32,056,244
Global health 18 942,789 5,427,337 -2,590,788 100,000 602,654 724,636 833,750 942,789 3,386,540 3,837,627 7,031,776 29,947,850 32,056,244
Sectors not specified 1 500 500 500 500 500 500 500 500 500 500 500 500 500

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008 2007 2006
Global health (filter this donor) 18 97,692,070.00 4,337,627.00 602,654.00 -1,757,038.00 6,226,952.00 942,789.00 4,111,176.00 9,778,596.00 680,000.00 3,733,444.00 7,031,776.00 29,947,850.00 32,056,244.00
Sectors not specified (filter this donor) 1 500.00 0.00 0.00 0.00 0.00 500.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total 19 97,692,570.00 4,337,627.00 602,654.00 -1,757,038.00 6,226,952.00 943,289.00 4,111,176.00 9,778,596.00 680,000.00 3,733,444.00 7,031,776.00 29,947,850.00 32,056,244.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of donations in reverse chronological order (19 donations)

Amount (current USD)Amount rank (out of 19)Donation dateCause areaURLInfluencerNotes
500,000.00162018-10-26Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to provide Good Manufacturing Practices material for human clinical trials and maintain clinical readiness of the facility and compliance with Food and Drug Administration regulations; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
3,837,627.0062018-01-25Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify new leads and new drug targets for tuberculosis suitable for further drug development with the ultimate goal of producing new drugs to treat tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
602,654.00152017-11-06Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to provide foundation grantees with novel and innovative industry quality adjuvants and formulations to enhance the success of pre-clinical and clinical vaccine development; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
833,750.00112016-08-26Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify new leads and new drug targets for tuberculosis suitable for further drug development with the ultimate goal of producing new drugs to treat tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-2,590,788.00192016-05-19Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to eliminate leishmaniasis by developing a vaccine for use in both treatment and prevention; Aid type: Project-type interventions. Affected regions: South America|Africa; affected countries: India|Bangladesh.
4,349,073.0052015-10-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to enhance IDRI’s capabilities to provide industry quality adjuvants and formulations for the development of vaccines for diseases in the developing world; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
773,722.00122015-10-05Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to provide foundation grantees with novel and innovative industry quality adjuvants and formulations to enhance the success of pre-clinical and clinical vaccine development; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
1,004,157.0092015-09-11Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to provide Good Manufacturing Practices material for human clinical trials and maintain clinical readiness of the facility and compliance with Food and Drug Administration regulations; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
100,000.00172015-04-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide support to launch Global Health Vaccine Accelerator Platform (GH-VAP) for the adjuvants and formulations platform; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
942,789.00102014-11-04Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify new leads and new drug targets for tuberculosis suitable for further drug development with the ultimate goal of producing new drugs to treat tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
500.00182014-09-22Sectors not specifiedhttps://iatiregistry.org/publisher/bmgf-- to support the Starting Gates partnership. Starting Gates 8/12/14. Investment start date: 9/22/2014 to end date: 9/26/2014. Grantee name: Infectious Disease Research Institute; Aid type: Project-type interventions. Affected countries: United states of america (the).
3,386,540.0082013-10-30Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify new leads and new drug targets for tuberculosis suitable for further drug development with the ultimate goal of producing new drugs to treat tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
724,636.00132013-10-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a research tool to identify individuals infected with Leishmania donovani parasites in the absence of visceral leishmaniasis disease to better understand their role in transmission.; Aid type: Project-type interventions. Affected regions: South of Sahara|South America; affected countries: India|Bangladesh.
9,778,596.0032012-11-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop and provide access to industry quality adjuvants and formulations to foundation grantees/collaborators and to bring forward one lead vaccine candidate for a foundation high priority disease.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
680,000.00142011-11-07Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify new leads and new drug targets for tuberculosis suitable for further drug development with the ultimate goal of producing new drugs to treat tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
3,733,444.0072010-11-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify new leads and new drug targets for tuberculosis suitable for further drug development with the ultimate goal of producing new drugs to treat tuberculosis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
7,031,776.0042008-10-28Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a highly specific diagnostic test and an accurate test of cure for visceral leishmaniasis; Aid type: Project-type interventions. Affected regions: Africa.
29,947,850.0022007-11-01Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to provide adjuvants for priority vaccine candidates with emphasis on malaria. Adjuvant to Enable New Vaccines Product Development Partnership. Investment start date: 10/14/2007 to end date: 6/30/2014. Grantee name: Infectious Disease Research Institute; Aid type: Project-type interventions. Affected regions: South of Sahara.
32,056,244.0012006-08-07Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to eliminate leishmaniasis by developing a vaccine for use in both treatment and prevention; Aid type: Project-type interventions. Affected regions: South America|Africa; affected countries: India|Bangladesh.